Cytophage Technologies Ltd.’s Reverse Takeover and TSX Listing

Wildeboer Dellelce LLP acted for CTI on the matter. Cytophage Technologies Ltd. (“Cytophage”), formerly Cuspis Capital III Ltd., has completed a reverse take-over (the “RTO”) of…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now